Brief: Transgene, Bioinvent To Present Translational Data And Updated Clinical Results On Armed Oncolytic Virus Bt-001
13/10/2025 07:48
Oct 13 (Reuters) - BioInvent International AB BINV.ST: TRANSGENE AND BIOINVENT TO PRESENT TRANSLATIONAL DATA AND UPDATED CLINICAL RESULTS ON ARMED ONCOLYTIC VIRUS BT-001, AT ESMO 2025 DATA SHOWED ENCOURAGING AND SUSTAINED ANTI-TUMOR ACTIVITY IN PATIENTS WITH ADVANCED REFRACTORY TUMORS. Source text: ID:nMFN5FGJ7s Further company coverage: BINV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))